Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michele Annette Gadd, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Michele Gadd and Kevin Hughes.
Michele Gadd
Connection Strength
2.395
Kevin Hughes
  1. Incidental breast carcinoma: incidence, management, and outcomes in 4804 bilateral reduction mammoplasties. Breast Cancer Res Treat. 2019 Oct; 177(3):741-748.
    View in: PubMed
    Score: 0.206
  2. Reassessing risk models for atypical hyperplasia: age may not matter. Breast Cancer Res Treat. 2017 Sep; 165(2):285-291.
    View in: PubMed
    Score: 0.178
  3. Using machine learning to parse breast pathology reports. Breast Cancer Res Treat. 2017 01; 161(2):203-211.
    View in: PubMed
    Score: 0.171
  4. The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions. Breast Cancer Res Treat. 2012 Dec; 136(3):627-33.
    View in: PubMed
    Score: 0.130
  5. The feasibility of using natural language processing to extract clinical information from breast pathology reports. J Pathol Inform. 2012; 3:23.
    View in: PubMed
    Score: 0.127
  6. The American Cancer Society guidelines for breast screening with magnetic resonance imaging: an argument for genetic testing. Cancer. 2008 Dec 01; 113(11):3116-20.
    View in: PubMed
    Score: 0.099
  7. Accuracy of self-reported personal history of cancer in an outpatient breast center. J Genet Couns. 2007 Jun; 16(3):341-5.
    View in: PubMed
    Score: 0.089
  8. Prevalence of hereditary breast/ovarian carcinoma risk in patients with a personal history of breast or ovarian carcinoma in a mammography population. Cancer. 2005 Nov 01; 104(9):1849-53.
    View in: PubMed
    Score: 0.080
  9. ASO Visual Abstract: Nipple-Sparing Mastectomy Versus Skin-Sparing Mastectomy-Does Saving the Nipple Have an Impact on Short- and Long-Term Patient Satisfaction? Ann Surg Oncol. 2022 Feb; 29(2):1041-1042.
    View in: PubMed
    Score: 0.062
  10. Magnetic Seeds: An Alternative to Wire Localization for Nonpalpable Breast Lesions. Clin Breast Cancer. 2022 Jan 17.
    View in: PubMed
    Score: 0.061
  11. ASO Visual Abstract: How Protective are Nipple-Sparing Prophylactic Mastectomies in BRCA1 and BRCA2 Mutation Carriers? Ann Surg Oncol. 2021 Dec; 28(Suppl 3):594-595.
    View in: PubMed
    Score: 0.061
  12. Nipple-Sparing Mastectomy versus Skin-Sparing Mastectomy: Does Saving the Nipple Impact Short- and Long-Term Patient Satisfaction? Ann Surg Oncol. 2022 Feb; 29(2):1033-1040.
    View in: PubMed
    Score: 0.060
  13. How Protective are Nipple-Sparing Prophylactic Mastectomies in BRCA1 and BRCA2 Mutation Carriers? Ann Surg Oncol. 2021 Oct; 28(10):5657-5662.
    View in: PubMed
    Score: 0.059
  14. Performance of a novel protease-activated fluorescent imaging system for intraoperative detection of residual breast cancer during breast conserving surgery. Breast Cancer Res Treat. 2021 May; 187(1):145-153.
    View in: PubMed
    Score: 0.058
  15. Node-Positive Patients Treated with Neoadjuvant Chemotherapy Can Be Spared Axillary Lymph Node Dissection with Wireless Non-Radioactive Localizers. Ann Surg Oncol. 2020 Nov; 27(12):4819-4827.
    View in: PubMed
    Score: 0.055
  16. Long-Term Outcomes of Multiple-Wire Localizations for More Extensive Breast Cancer: Multiple-Wire Excision Does Not Increase Recurrence, Unplanned Imaging, or Biopsies. Clin Breast Cancer. 2020 06; 20(3):215-219.
    View in: PubMed
    Score: 0.053
  17. Enhanced Recovery Minimizes Opioid Use and Hospital Stay for Patients Undergoing Mastectomy with Reconstruction. Ann Surg Oncol. 2019 Oct; 26(11):3464-3471.
    View in: PubMed
    Score: 0.052
  18. Trends in Unilateral and Contralateral Prophylactic Mastectomy Use in Ductal Carcinoma In Situ of the Breast: Patterns and Predictors. Ann Surg Oncol. 2019 Nov; 26(12):3863-3873.
    View in: PubMed
    Score: 0.052
  19. Radiofrequency identification tag localization is comparable to wire localization for non-palpable breast lesions. Breast Cancer Res Treat. 2019 Oct; 177(3):735-739.
    View in: PubMed
    Score: 0.052
  20. Nipple Discharge After Nipple-Sparing Mastectomy With and Without Associated Pregnancy. Clin Breast Cancer. 2019 08; 19(4):e534-e539.
    View in: PubMed
    Score: 0.050
  21. Twenty-Five Year Trends in the Incidence of Ductal Carcinoma in Situ in US Women. J Am Coll Surg. 2019 06; 228(6):932-939.
    View in: PubMed
    Score: 0.050
  22. Factors Associated with Recurrence Rates and Long-Term Survival in Women Diagnosed with Breast Cancer Ages 40 and Younger. Ann Surg Oncol. 2016 10; 23(10):3212-20.
    View in: PubMed
    Score: 0.042
  23. Should New "No Ink On Tumor" Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins. Ann Surg Oncol. 2016 10; 23(11):3453-3458.
    View in: PubMed
    Score: 0.041
  24. Prediction of primary breast cancer size and T-stage using micro-computed tomography in lumpectomy specimens. J Pathol Inform. 2015; 6:60.
    View in: PubMed
    Score: 0.040
  25. Lumpectomy specimen margins are not reliable in predicting residual disease in breast conserving surgery. Am J Surg. 2015 Jul; 210(1):93-8.
    View in: PubMed
    Score: 0.038
  26. Surgical excision of radial scars diagnosed by core biopsy may help predict future risk of breast cancer. Breast Cancer Res Treat. 2014 Jun; 145(2):331-8.
    View in: PubMed
    Score: 0.036
  27. Application of ACOSOG Z0011 criteria reduces perioperative costs. Ann Surg Oncol. 2013 Mar; 20(3):836-41.
    View in: PubMed
    Score: 0.032
  28. Sentinel lymph node biopsy at the time of mastectomy does not increase the risk of lymphedema: implications for prophylactic surgery. Breast Cancer Res Treat. 2012 Oct; 135(3):781-9.
    View in: PubMed
    Score: 0.032
  29. Cost comparison of radiation treatment options after lumpectomy for breast cancer. Ann Surg Oncol. 2012 Oct; 19(10):3275-81.
    View in: PubMed
    Score: 0.032
  30. Lumpectomy cavity shaved margins do not impact re-excision rates in breast cancer patients. Ann Surg Oncol. 2011 Oct; 18(11):3036-40.
    View in: PubMed
    Score: 0.030
  31. The safety of multiple re-excisions after lumpectomy for breast cancer. Ann Surg Oncol. 2011 Dec; 18(13):3797-801.
    View in: PubMed
    Score: 0.029
  32. Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging. Am J Surg. 2009 Oct; 198(4):538-43.
    View in: PubMed
    Score: 0.026
  33. Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion? Am J Surg. 2008 Oct; 196(4):566-8.
    View in: PubMed
    Score: 0.024
  34. Outcomes of multiple wire localization for larger breast cancers: when can mastectomy be avoided? J Am Coll Surg. 2008 Sep; 207(3):342-6.
    View in: PubMed
    Score: 0.024
  35. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ. Ann Surg Oncol. 2008 Jan; 15(1):268-73.
    View in: PubMed
    Score: 0.023
  36. Detecting occult malignancy in prophylactic mastectomy: preoperative MRI versus sentinel lymph node biopsy. Ann Surg Oncol. 2007 Sep; 14(9):2477-84.
    View in: PubMed
    Score: 0.022
  37. Accelerated partial-breast irradiation using proton beams: initial clinical experience. Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):691-8.
    View in: PubMed
    Score: 0.021
  38. Breast cancer diagnosis in women < or = 40 versus 50 to 60 years: increasing size and stage disparity compared with older women over time. Ann Surg Oncol. 2006 Aug; 13(8):1072-7.
    View in: PubMed
    Score: 0.021
  39. Initial dosimetric experience using simple three-dimensional conformal external-beam accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys. 2006 Mar 15; 64(4):1092-9.
    View in: PubMed
    Score: 0.020
  40. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. Am J Surg. 2005 Oct; 190(4):517-20.
    View in: PubMed
    Score: 0.020
  41. Evaluation of hereditary risk in a mammography population. Clin Breast Cancer. 2005 Apr; 6(1):38-44.
    View in: PubMed
    Score: 0.019
  42. Breast cancer treatment in older women. Surg Oncol Clin N Am. 2005 Jan; 14(1):85-102, vi.
    View in: PubMed
    Score: 0.019
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.